Abstract
Interleukin-6 (IL-6) is a multifunctional cytokine produced by both lymphoid and nonlymphoid cells (Kishimoto and Hirano 1988 a, b; Kishimoto 1988; Le and Vilcek 1989). IL-6 has previously been called by a variety of names, such as B-cell stimulatory factor 2 (BSF-2; Hirano et al. 1985), interferon-β2 (IFN-β2; Zilberstein et al. 1986), 26-kDa protein (Haegeman et al. 1986), hybridoma/plasmacytoma growth factor (Van Snick et al. 1986; Nordan and Potter 1986; Van Damme et al. 1987 a), and hepatocyte stimulating factor (HSF; Andus et al. 1987; Gauldie et al. 1987) on the basis of its biological activities. Following the molecular cloning of the cDNAs encoding BSF-2, IFN-β2, and 26-kDa protein (Hirano et al. 1986; Zilberstein et al. 1986; Haegeman et al. 1986), it was found that all these molecules were identical and therefore this molecule was called IL-6. It is now known that IL-6 is a polypeptide mediator regulating the immune response, the acute phase reaction, and hematopoiesis. Furthermore, it has been demonstrated that deregulated production of IL-6 is involved in a variety of chronic inflammatory diseases and certain lymphoid malignancies, especially plasmacytoma/myeloma. In fact, it was demonstrated that unregulated expression of the IL-6 gene in B-lineage cells causes development of a massive plasmacytosis histologically indistinguishable from plasmacytoma in transgenic mice with the immunoglobulin heavy chain enhancer—IL-6 gene (Suematsau et al. 1989).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aarden LP, Lansdorp, De Groot E (1985) A growth factor for B cell hybridomas produced by human monocytes. Lymphokines 10: 175–185
Andus T, Geiger T, Hirano T, Northoff H, Ganter U, Bauer J, Kishimoto T, Heinrich PC (1987) Recombinant human B cell stimulatory factor 2 (BSF-2/IFNß 2) regulates ß-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett 221: 18–22
Astaldi GCB, Janssen MC, Lansdorp PM, Willems C, Zeijlemaker WP, Oosterhof F (1980) Human endothelial culture supernatant (HECS): a growth factor for hybridomas. J Immunol 125: 1411–1414
Bowcock AM, Kidd JR, Lathrop M, Danshvar L, May LT, Ray A, Sehgal PB, Kidd KK, Cavallisforza LL (1988) The human “beta-2 interferon/hepatocyte stimulating factor/interleukin-6” gene: DNA polymorphism studies and localization to chromosome 7p21. Genomics 3: 8–16
Brakenhoff JPJ, de Groot ER, Evers RF, Pannekoek H, Aarden LA (1987) Molecular cloning and expression of hybridoma growth factor in Escherichia coli J Immunol 139: 4116–4121
Cancro M, Potter M (1976) The requirement of an adherent substratum for the growth of developing plasmacytoma cells in vivo. J Exp Med 144: 1554–1567
Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, Heinrich PC (1988a) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232: 347350
Castell JV, Geiger T, Gross V, Andus T, Walter E, Hirano T, Kishimoto T, Heinrich PC (1988b) Plasma clearance, organ distribution, and target cells of interleukin6/hepatocyte stimulating factor in the rat. Eur J Biochem 177: 357–361
Chen L, Mory Y, Zilberstein A, Revel M (1988) Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant IFN-beta2 (BSF-2). Proc Natl Acad Sci USA 85: 8037–8041
Chen Y, Ferguson-Smith AC, Newman MS, May LT, Sehgal PB, Ruddle FH (1987) Regional localization of the human B2-interferon gene. Am J Hum Genet 41: A161
Content J, De Wit L, Pierard D, Derynck R, de Clercq E, Fiers W (1982) Secretory proteins induced in human fibroblasts under conditions used for the production of interferon ß. Proc Natl Acad Sci USA 79: 2768–2772
Content J, De Wit L, Poupart P, Opdenakker G, Van Damme J, Billiau A (1985) Induction of a 26-kDa-protein mRNA in human cells treated with an interleukin-1related, leukocyte-derived factor. Eur J Biochem 152: 253–257
Corbel C, Melchers F (1984) The synergism of accessory cells and of soluble a-factors derived from them in the activation of B cells to proliferation Immunol Rev 78: 51–74
Coulie PG, Vanhecke A, Van Damme J, Cayphas S, Poupart P, De Wit L, Content J (1987) High affinity sites for human 26-kDa protein (interleukin 6, B-cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type-1 interferon (alpha, beta) on lymphoblastoid cells. Eur J Immuno117: 1435–1440
Dutton RW, Falkoff R, Hirst JA, Hoffman M, Kappler JW, Kattman JR, Lesley JF, Vann D (1971) Is there evidence for a nonantigen specific diffusable chemical mediator from the thymus cell in the initiation of the immune response? Prog Immunol 1: 355–368
Frei K, Leist TP, Meager A, Gallo P, Leppert D, Zinkernagel RM, Fontana A (1988) Production of B cell stimulatory factor-2 and interferon y in the central nervous system during viral meningitis and encephalitis. J Exp Med 168: 449–453
Garman RD, Jacobs KA, Clark SC, Raulet DH (1987) B-cell-stimulatory factor 2 (ß 2 interferon) functions as a second signal for interleukin 2 production by mature murine T cells. Proc Natl Acad Sci USA 84: 7629–7633
Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H (1987) Interferon ß 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocytestimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84: 7251–7255
Gearing D, Gough NM, King JA, Hilton DJ, Nicola NA, Simpson RJ, Nice EC, Kelso A, Metcalf D (1987) Molecular cloning and expression of cDNA encoding a murine myeloid leukaemia inhibitory factor ( LIF ). EMBO J 6: 3995–4002
Geiger T, Andus T, Klapproth J, Hirano T, Kishimoto T, Heinrich PC (1988) Induc- tion of rat acute-phase proteins by interleukin-6 in vivo. Eur J Immunol 18: 717–721
Haegeman G, Content J, Volckaert G, Derynck R, Tavernier J, Fiers W (1986) Structural analysis of the sequence encoding for an inducible 26-kDa protein in human fibroblasts. Eur J Biochem 159: 625–632
Helfgott DC, May LT, Sthoeger Z, Tamm I, Sehgal PB (1987) Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of ß 2 interferon by human fibroblasts. J Exp Med 166: 1300–1309
Helle M, Brakenhoff JPJ, De Groot ER, Aarden LA (1988) Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 18: 957–959
Hirano T, Teranishi T, Onoue K (1984a) Human helper T cell factor(s) III. Characterization of B cell differentiation factor I ( BCDFI ). J Immunol 132: 229–234
Hirano T, Teranishi T, Lin BH, Onoue K (1984b) Human helper T cell factor(s) IV. Demonstration of a human late-acting B cell differentiation factor acting in Staphylococcus aureus Cowan I-stimulated B cells. J Immunol 133: 798–802
Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, Kishimoto T (1985) Purification to homogeneity and characterization of human B cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 82: 5490–5494
Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73–76
Hirano T, Taga T, Yasukawa K, Nakajima K, Nakano N, Takatsuki F, Shimizu M, Murashima A, Tsunasawa S, Sakiyama F, Kishimoto T (1987) Human B cell differentiation factor defined by an anti-peptide antibody and its possible role in autoantibody production. Proc Natl Acad Sci USA 84: 228–231
Hirano T, Matsuda T, Hosoi K, Okano A, Matsui H, Kishimoto T (1988 a) Absence of antiviral activity in recombinant B cell stimulatory factor 2 (BSF-2). Immunol Lett 17: 41–45
Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldman M, Kishimoto T (1988 b) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 18: 1797–1801
Hodgkin PD, Bond MW, O’Garra A, Frank G, Lee F, Coffman RL, Zlotnik A, Howard M (1988) Identification of IL-6 as a T cell-derived factor that enhances the proliferative response of thymocytes to IL-4 and phorbol myristate acetate. J Immuno1141: 151–157
Horii Y, Muraguchi A, Suematu S, Matsuda T, Yoshizaki K, Hirano T, Kishimoto T (1988) Regulation of BSF-2/IL-6 production by human mononuclear cells: macrophage-dependent synthesis of BSF-2/IL-6 by T cells. J Immunol 141: 1529–1535
Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y, Yoshizaki K, Hirano T, Kishimoto T (1989) Involvement of interleukin-6 in mesangial proliferative glomerulonephritis. J Immunol 143 (in press)
Houssiau FA, Coulie PG, Olive D, Van Snick J (1988) Synergistic activation of human T cells by interleukin 1 and interleukin 6. Eur J Immunol 18: 653–656
Ichikawa Y (1969) Differentiation of a cell line of myeloid leukemia. J Cell Physiol 74: 223–234
Ikebuchi K, Wong GG, Clark SC, Ihle JN, Hirai Y, Ogawa M (1987) Interleukin-6 enhancement of interleukin-3-dependent proliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci USA 84: 9035–9039
Ishibashi T, Kimura H, Uchida T, Karyone S, Friese P, Burstein SA (1989a) Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro. Proc Natl Acad Sci USA 86: 5953–5957
Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y (1989 b) Interleukin 6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241–1244
Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, Kishimoto T (1988) Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332: 83–85
Kikutani H, Taga T, Akira S, Kishi H, Miki Y, Saiki O, Yamamura Y, Kishimoto T (1985) Effect of B cell differentiation factor ( BCDF) on biosynthesis and secretion of immunoglobulin molecules in human B cell lines. J Immunol 134: 990–995
Kishimoto T (1985) Factors affecting B cell growth and differentiation. Annu Rev Immunol 3: 133–159
Kishimoto T (1988) B cell differentiation–interleukins and receptors for the antibody response. ISI Atlas of Science: Immunology 1: 149–154
Kishimoto T, Hirano T (1988 a) Molecular regulation of B lymphocyte response. Annu Rev Immunol 6: 485–512
Kishimoto T, Hirano T (1988 b) A new interleukin with pleiotropic activities. Bioessays 9: 11–15
Kishimoto T, Ishizaka K (1973) Regulation of antibody responses in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response. J Immunol 111: 1194–1205
Kohase M, May LT, Tamm I, Vilcek J, Sehgal PB (1987) A cytokine network in human diploid fibroblasts: interactions of ß-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol 7: 273–280
Koji A (1985) Definition and classification of acute-phase proteins. In: Gordon AH, Koji A (eds) The acute phase response to injury and infection. Elsevier, Amsterdam, p 139 (Research monographs in cell and tissue physiology, vol 10 )
Koji A, Gauldie J, Regoeczi E, Sauder DN, Sweeney GD (1984) The acute-phase response of cultured rat hepatocytes. System characterization and the effect of human cytokines. Biochem J 224: 505–514
Kushner I (1982) The phenomenon of the acute phase response. Ann NY Acad Sci 389: 39–48
Le J, Vilcek J (1989) Interleukin 6. In: Barr PJ (ed) Growth factors and lymphokines: production and clinical application. Dekker, New York (in press)
Le J, Fredrickson G, Reis LFL, Diamantsein T, Hirano T, Kishimoto T, Vilcek J (1988) Interleukin 2-dependent and interleukin 2-independent pathways of regulation of thymocyte function by interleukin 6. Proc Natl Acad Sci USA 85: 8643–8647
Lee F, Yokota T, Otsuka T, Meyerson P, Villaret D, Coffman R, Mosmann T, Rennick D, Roehm N, Smith C, Zlotnik A, Arai L (1986) Isolation and characterization of a mouse interleukin cDNA clone that expresses BSF-1 activities and T cell and mast cell stimulatory activities. Proc Natl Acad Sci USA 83: 2061–2065
Lipton JH, Sachs L (1981) Characterization of macrophage-and granulocyte-inducing proteins for normal and leukemic myeloid cells produced by the Krebs ascites tumor. Biochim Biophys Acta 673: 552–569
Lotz M, Jirik F, Kabouridis R, Tsoukas C, Hirano T, Kishimoto T, Carson DA (1988) BSF-2/IL-6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med 167: 1253–1258
Lovett DH, Ryan JL, Sterzel RB (1983) Stimulation of rat mesangial cell proliferation by macrophage interleukin 1. J Immuno1131: 2830–2836
MacCarthy EP, Hsu A, Ooi BS (1985) Modulation of mouse mesangial cell proliferation by macrophage products. Immunology 56: 695–699
Matsuda T, Hirano T, Kishimoto T (1988) Establishment of a IL-6/BSF-2-dependent cell line and preparation of anti-IL-6/BSF-2 monoclonal antibodies. Eur J Immunol 18: 951–956
Matsuda T, Hirano T, Nagasawa S, Kishimoto T (1989) Identification of a2-macroglobulin as a carrier protein for interleukin 6. J Immunol 142: 148–152
May LT, Helfgott DC, Sehgal PB (1986) Anti-ß-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the ß2-interferon involved. Proc Natl Acad Sci USA 83: 8957–8961
Melcion C, Lachman L, Killen PD, Morel-Maroger L, Stricker GE (1982) Mesangial cells, effect of monocyte products on proliferation and matrix synthesis. Transplant Proc 14: 559–564
Metcalf D (1974) The serum factor stimulating colony formation in vitro by murine plasmacytoma cells: response to antigens and mineral oil. J Immunol 113: 235–243
Metcalf D (1986) The molecular biology and functions of the granulocyte-macrophage colony-stimulating factors. Blood 67: 257–267
Miyaura C, Onozaki K, Akiyama Y, Taniyama T, Hirano T, Kishimoto T, Suda T (1988) Recombinant human interleukin 6 (B-cell stimulatory factor 2) is a potent inducer of differentiation of mouse myeloid leukemia cells ( M1 ). FEBS Lett 234: 17–21
Mosmann TR, Coffman RL (1987) Two types of helper T-cell clone: implications for immune regulation. Immunol Today 8: 223–227
Muraguchi A, Kishimoto T, Miki Y, Kuratani T, Kaieda T, Yoshizaki K, Yamamura Y (1981) T cell-replacing factor ( TRF)-induced IgG secretion in human B blastoid cell line and demonstration of acceptors for TRF. J Immunol 127: 412–416
Muraguchi A, Hirano T, Tang B, Matsuda T, Horii Y, Nakajima K, Kishimoto T (1988) The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells. J Exp Med 167: 332–344
Mushinski JF, Bauer SR, Potter M, Reddy EP (1983) Increased expression of mycrelated oncogene mRNA characterizes most BALB/c plasmacytomas induced by pristane and Abelson murine leukemia virus. Proc Natl Acad Sci USA 80: 1073–1077
Nagata S, Tsuchiya M, Asano S, Kaziro Y, Yamazaki T, Yamamoto O, Hirata Y, Kubota N, Oheda M, Nomura H, Ono M (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319: 415–418
Nakajima K, Martinez-Maza O, Hirano T, Nishanian P, Salazar-Gonzalez JF, Fahey JL, Kishimoto T (1989) Induction of interleukin 6(BSF-2/IFN-ß 2) production by the human immunodeficiency virus ( HIV ). J Immunol 142: 144–147
Namba Y, Hanaoka M (1972) Immunocytology of cultured IgM-forming cells of mouse. I. Requirement of phagocytic cell factor and its role in antibody formation. J Immunol 109: 1193–1200
Nicola NA, Metcalf D, Matsumoto M, Johnson GR (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J Biol Chem 258: 9017–9023
Nijstein MWN, De Groot ER, Ten Duis HJ, Klasen HJ, Hack CE, Aarden LA (1987) Serum levels of interleukin-6 and acute phase responses. Lancet ii: 921
Noma T, Mizuta T, Rosen A, Hirano T, Kishimoto T, Honjo T (1987) Enhancement of the interleukin 2 receptor expression on T cells by multiple B-Iymphotropic lymphokines. Immunol Lett 15: 249–253
Nordan RP, Potter M (1986) A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233: 566–569
Nordan RP, Pumphrey JG, Rudikoff S (1987) Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. J Immuno1139: 813–817
Ohno S, Babonits M, Wiener F, Spira J, Klein G, Potter M (1979) Non-random chromosome changes involving the Ig gene-carrying chromosomes 12 and 6 in pristaneinduced mouse plasmacytomas. Cell 18: 1001–1007
Okada M, Sakaguchi N, Yoshimura N, Hara H, Shimizu K, Yoshida N, Yoshizaki K, Kishimoto S, Yamamura Y, Kishimoto T (1983) B cell growth factor (BCGF) and B cell differentiation factor from human T hybridomas: two distinct kinds of BCGFs and their synergism in B cell proliferation. J Exp Med 157: 583–590
Okada M, Kitahara M, Kishimoto S, Matsuda T, Hirano T, Kishimoto T (1988) BSF2/IL-6 functions as killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 141: 1543–1549
Okano A, Suzuki C, Takatsuki F, Akiyama Y, Kake K, Ozawa K, Hirano T, Kishimoto T, Nakahata T, Asano S (1989) In vitro expansion of murine pluripotent hemopoietic stem cell population in response to interleukin 3 and interleukin 6: application to bone marrow transplantation. Transplantation 48: 495–498
Potter M, Boyce C (1962) Induction of plasma cell neoplasms in strain Balb/c mice with mineral oil and mineral oil adjuvants. Nature 193: 1086–1087
Poupart P, Vandenabeele P, Cayphas S, Snick JV, Haegeman G, Kruys V, Fiers W, Content J (1987) B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-ß 2, HPGF ). EMBO J 6: 1219–1224
Prud’homme GJ, Fieser TM, Dixon FJ, Theofilopoulos AN (1984) B cell-tropic inter- leukins in murine systemic lupus erythematosus ( SLE ). Immunol Rev 78: 159–183
Ray A, Tatter SB, May LT, Sehgal PB (1988) Activation of the human “ß 2interferon/hepatocyte-stimulating factor/interleukin 6” promoter by cytokines, viruses, and second messenger agonists. Proc Natl Acad Sci USA 85: 6701–6705
Reis LL, Le J, Hirano T, Kishimoto T, Vilcek J (1988) Antiviral action of tumor necrosis factor in human fibroblasts is not mediated by B cell stimulatory factor 2/IFN-ß 2, and is inhibited by specific antibodies to IFN-ß. J Immunol 140: 1566–1570
Sachs L (1978) Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukemia. Nature 274: 535–539
Sachs L (1987) The molecular control of blood cell development. Science 238: 1374–1379
Sanderson CL, O’Garra A, Warren DJ, Klaus GGB (1986) Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc Natl Acad Sci USA 83: 437–440
Satoh T, Nakamura S, Taga T, Matsuda T, Hirano T, Kishimoto T, Kaziro Y (1988) Induction of neural differentiation in PC12 cells by B cell stimulatory factor 2/interleukin 6. Mol Cell Biol 8: 3546–3549
Schimpl A, Wecker E (1972) Replacement of T cell function by a T cell product. Nature 237: 15–17
Sehgal PB, Zilberstein A, Ruggieri R-M, May LT, Ferguson-Smith A, Slate DL, Revel M, Ruddle F (1986) Human chromasome 7 carries the ß 2 interferon gene. Proc Natl Acad Sci USA 83: 5219–5222
Sehgal PB, Walther Z, Tamm I (1987) Rapid enhancement of ß 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187. Proc Natl Acad Sci USA 84: 3633–3667
Sehgal PB, Helfgott DC, Santhanam U, Tatter SB, Clarick RH, Ghrayeb J, May LT (1988) Regulation of the acute phase and immune responses in viral disease. J Exp Med 167: 1951–1956
Shabo Y, Lotem J, Rubinstein M, Revel M, Clark SC, Wolf SF, Kamen R, Sachs L (1988) The myeloid blood cell differentiation-inducing protein MGI-2A is interleukin 6. Blood 72: 2070–2073
Shaw G, Kamen R (1986) A conserved AU sequence from the 3’ untranslated region of GM-CSF mRNA mediates selective degradation. Cell 46: 659–667
Shimizu S, Hirano T, Yoshioka K, Sugai S, Matsuda T, Taga T, Kishimoto T, Konda S (1988) Interleukin 6 (B cell stimulatory factor 2)-dependent growth of a Lennert’s lymphoma-derived T cell line (KT-3). Blood 72: 1826–1828
Sims JE, March CJ, Cosman D, Widmer MB, MacDonald HR, McMahan CJ, Grubin CE, Wignall JM, Jackson JL, Call SM, Friend D, Alpert AR, Gillis S, Urdal DL, Dower SK (1988) cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily. Science 241: 585–589
Sporn MB, Roberts AB (1988) Peptide growth factors are multifunctional. Nature 332:217–219 Striker GE, Striker LJ (1985) Biology of disease: glomerular cell culture. Lab Invest 53: 122–131
Suematsu S, Matsuda T, Aozasa K, Akira S, Nakao N, Ohno S, Miyazaki J, Jamamura K, Hirano T, Kishimoto T (1989) IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci USA 86: 7547–7551
Sutton MGSJ, Mercier L, Giuliani ER, Lie JT (1980) Atrial myxomas: a review of clinical experience in 40 patients. Mayo Clin Proc 55: 371–376
Taga T, Kawanishi K, Hardy RR, Hirano T, Kishimoto T (1987) Receptors for B cell stimulatory factor 2 (BSF-2): quantitation, specificity, distribution and regulation of the expression. J Exp Med 166: 967–981
Taga T, Hibi M, Hirata Y, Yamasaki K, Yasakawa K, Matsuda T, Hirano T, Kishimoto T (1989) Interleukin-6 (IL-6) triggers the association of its receptor (IL-6-R) with a possible signal transducer, gp 130. Cell 58: 573–581
Takai Y, Wong GG, Clark SC, Burakoff SJ, Herrmann SH (1988) B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes. J Immunol 140: 508–512
Takatsuki F, Okano A, Suzuki C, Chieda R, Takahara Y, Hirano T, Kishimoto T, Hamuro J, Akiyama Y (1988) Human recombinant interleukin 6/B cell stimulatory factor 2 (IL-6/BSF-2) augments murine antigen-specific antibody responses in vitro and in vivo. J Immunol 141: 3072–3077
Tanabe O, Akira S, Kamiya T, Wong GG, Hirano T, Kishimoto T (1988) Genomic structure of the murine IL-6 gene: high degree conservation of potential regulatory sequences between mouse and human. J Immunol 141: 3875–3881
Teranishi T, Hirano T, Arima N, Onoue K (1982) Human helper T cell factor(s) (ThF). II. Induction of IgG production in B lymphoblastoid cell lines and identification of T cell-replacing factor-(TRF) like factor(s). J Immunol 128: 1903–1908
Teranishi T, Hirano T, Lin BH, Onoue K (1984) Demonstration of the involvement of interleukin 2 in the differentiation of Staphylococcus aureus Cowan I-stimulated B cells. J Immunol 133: 3062–3067
Theofilopoulos AN, Dixon FJ (1985) Murine models of systemic lupus erythematosus. Adv Immunol 37: 269–390
Tomita M, Yamamoto-Yamaguchi Y, Hozumi M (1984) Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem 259: 10978–10982
Tomita M, Yamamoto-Yamaguchi Y, Hozumi M, Okabe T, Takaku F (1986) Induction by recombinant human granulocyte colony-stimulating factor of differentiation of mouse myeloid leukemic M1 cells. FEBS Lett 207: 271–275
Tosato G, Seamon KB, Goldman ND, Sehgal PB, May LT, Washington GC, Jones KD, Pike SE (1988) Monocyte-derived human B-cell growth factor identified as interferon-ß 2 (BSF-2, IL-6). Science 239: 502–504
Tsuchiya M, Shigetaka A, Kaziro Y, Nagata S (1986) Isolation and characterization of the cDNA for murine granulocyte colony-stimulating factor. Proc Natl Acad Sci USA 84: 7633–7637
Uyttenhove C, Coulie PG, Van Snick J (1988) T cell growth and differentiation induced by interleukin-Hpl/IL-6, the murine hybridoma/plasmacytoma growth factor. J Exp Med 167: 1417–1427
Van Damme J, De Ley M, Opdenakker G, Billiau A, De Somer P (1985) Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature 314: 266–268
Van Damme J, Opdenakker G, Simpson RJ, Rubira MR, Cayphas S, Vink A, Billiau A, Snick JV (1987 a) Identification of the human 26-kD protein, interferon ß 2 (IFNß 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor. J Exp Med 165: 914–919
Van Damme J, De Ley M, Van Snick J, Dinarello CA, Billiau A (1987b) The role of interferon-ß 1 and the 26-kDa protein (interferon-ß 2) as mediators of the antiviral effect of interleukin 1 and tumor necrosis factor. J Immunol 139: 1867–1872
Van Damme J, Cayphas S, Opdenakker G, Billiau A, Van Snick J (1987 c) Interleukin 1 and poly(rI)•poly(rC) induce production of a hybridoma growth factor by human fibroblasts. Eur J Immunol 17: 1–7
Van Snick J, Cayphas S, Vink A, Uyttenhove C, Coulie PG, Rubira MR, Simpson RJ (1986) Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci USA 83: 9679–9683
Van Snick J, Vink A, Cayphas S, Uyttenhove C (1987) Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas. J Exp Med 165: 641–649
Van Snick J, Cayphas S, Szikora J-P, Renauld J-C, Van Roost E, Boon T, Simpson RJ (1988) cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur J Immunol 18: 193–197
Vink A, Coulie PG, Wauters P, Nordan RP, Van Snick J (1988) B cell growth and differentiation activity of interleukin-HP1 and related murine plasmacytoma growth factors. Synergy with interleukin 1. Eur J Immunol 18: 607–612
Walther Z, May LT, Sehgal PB (1988) Transcriptional regulation of the interferon-ß 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines. J Immunol 140: 974–977
Weissenbach J, Chernajovsky Y, Zeevi M, Shulman L, Soreq H, Nir U, Wallach D, Perricaudet M, Tiollais P, Revel M (1980) Two interferon mRNA in human fibroblasts: in vitro translation and Escherichia coli cloning studies. Proc Natl Acad Sci USA 77: 7152–7156
Williams AF, Barclay AN (1988) The immunoglobulin superfamily–domains for cell surface recognition. Annu Rev Immunol 6: 381–405
Woloski BM, Smith EM, Meyer WJ, Fuller GM (1985) Corticotropin-releasing activity of monokines. Science 230: 1035–1037
Wong GHW, Goeddel DV (1986) Tumor necrosis factors a and ß inhibit virus replication and synergize with interferons. Nature 323: 819–822
Yamasaki K, Taga T, Hirata Y, Yawata H, Kawanishi Y, Seed B, Taniguchi T, Hirano T, Kishimoto T (1988) Cloning and expression of the human interleukin-6 (BSF2/IFNß) receptor. Science 241: 825–828
Yasukawa K, Hirano T, Watanabe Y, Muratani K, Matsuda T, Kishimoto T (1987) Structure and expression of human B cell stimulatory factor 2 (BSF-2/IL-6) gene. EMBO J 6: 2939–2945
Yoshizaki K, Nakagawa T, Kaieda T, Muraguchi A, Yamamura Y, Kishimoto T (1982) Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors. J Immunol 128: 1296–1301
Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, Komori T, Kishimoto S, Hirano T, Kishimoto T (1989) Pathological significance of interleukin 6 (IL-6/BSF-2) in Castleman’s disease. Blood 74: 1360–1367
Zhang Y, Lin J-X, Vilcek J (1988 a) Synthesis of interleukin 6 (interferon-ß 2/B cell stimulatory factor 2) in human fibroblasts is triggered by an increase in intracellular cyclic AMP. J Biol Chem 263: 6177–6182
Zhang Y, Lin J-X, Yip YK, Vilcek J (1988 b) Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6. Proc Natl Acad Sci USA 85: 6802–6805
Zilberstein A, Ruggieri R, Korn JH, Revel M (1986) Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines. EMBO J 5: 2529–2537
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Hirano, T., Kishimoto, T. (1990). Interleukin-6. In: Sporn, M.B., Roberts, A.B. (eds) Peptide Growth Factors and Their Receptors I. Handbook of Experimental Pharmacology, vol 95 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-49295-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-49295-2_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-49297-6
Online ISBN: 978-3-642-49295-2
eBook Packages: Springer Book Archive